Skin Care News

ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.

Almirall has completed the decentralized regulatory procedure in Europe for efinaconazole for the treatment of onychomycosis, the company announced in a press release.

The first over-the-counter monograph order request tier 1 application for bemotrizinol, an active sunscreen ingredient, has been submitted to the FDA, dsm-firmenich announced in a press release.

For patients using nemolizumab to treat prurigo nodularis, withdrawing medication led to a greater risk for relapse, according to a study presented at the European Academy of Dermatology and Venereology meeting.

Patients with bullous pemphigoid treated with Dupixent maintained disease control and symptom relief, according to phase 2/3 trial results released by Regeneron and Sanofi.

The FDA has missed its action date to address its proposed rule banning formaldehyde and formaldehyde-releasing chemicals from hair smoothing and straightening products.

The FDA has granted fast track designation to topically applied ATR-04 for the treatment of moderate to severe epidermal growth factor receptor inhibitor-associated dermal toxicity, Azitra announced in a press release.

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.

Patients with chronic spontaneous urticaria experienced a marked improvement with Dupixent treatment, according to phase 3 trial results released by Regeneron.

The use of personal care products was associated with endocrine-disrupting chemicals called phthalates in children aged as young as 4 years, according to a study.